| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/21/2011 | EP2366771A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366699A1 8-substituted isoquinoline derivative and use thereof |
| 09/21/2011 | EP2366389A1 Severe sepsis preventive therapeutic agent |
| 09/21/2011 | EP2365972A1 Modulators of atp-binding cassette transporters |
| 09/21/2011 | EP2365752A1 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities |
| 09/21/2011 | EP2365749A1 Quinolone neuropeptide s receptor antagonists |
| 09/21/2011 | EP1846035B1 Combination therapy |
| 09/21/2011 | EP1684793B1 Pharmaceutical composition comprising an insulinotropic glp-1(7-37) analogue, asp(b28)-insulin, and a surfactant |
| 09/21/2011 | EP1674106B1 Dietetic composition |
| 09/21/2011 | EP1641823B1 Glp-1 analog fusion plroteins |
| 09/21/2011 | EP1572240B1 Compositions, methods, and kits useful for the alleviation of gastrointestinal side effects of lipase inhibitors |
| 09/21/2011 | EP1274464B1 Compositions and methods for regulated protein expression in gut |
| 09/21/2011 | EP1200385B2 Process for the preparation of crystals of the sodium salt of pravastatin |
| 09/21/2011 | EP0871474B2 Generation of human insulin |
| 09/21/2011 | CN1931318B Chines medicine composition for treating children rickets and other acalcicosis symptoms and its prepn process |
| 09/21/2011 | CN1864434B Wireless microphone communication system |
| 09/21/2011 | CN102197044A Peptide having anti-diabetic activity and use thereof |
| 09/21/2011 | CN102197019A Thyroid receptor ligands |
| 09/21/2011 | CN102196810A Pharmaceutical composition improved in absorption through intestinal tract |
| 09/21/2011 | CN102196733A Method for concentrating lipid |
| 09/21/2011 | CN102191207A Gene engineering bacterium of expression of soluble FGF-21 and construction method and application thereof |
| 09/21/2011 | CN102191153A Burdock-water caltrop pulp health wine and production method thereof |
| 09/21/2011 | CN102190659A Phenylpyrazine compounds, and preparation method and medicinal application thereof |
| 09/21/2011 | CN102190632A 2,4,5-trisubstituted selenazole compounds and preparation method, compositions and application thereof |
| 09/21/2011 | CN102190589A Amino acid ionic liquid for foodstuffs and medical treatments |
| 09/21/2011 | CN102188709A Combined pharmaceutical formulation with controlled-release comprising dihydropyridine calcium channel blockers and HMG-CoA reductase inhibitors |
| 09/21/2011 | CN102188706A Fluvastatin tablet containing antiflatulent agent |
| 09/21/2011 | CN102188705A Medicament composition containing bis cyclooctane derivatives |
| 09/21/2011 | CN102188694A Application of osteogenesis inducible factor |
| 09/21/2011 | CN102188693A Novel proteoglycan complex |
| 09/21/2011 | CN102188655A Molecular Chinese patent medicine for inhibiting defects of Lifei tablets and syndromes of pulmonary tuberculosis |
| 09/21/2011 | CN102188651A Traditional Chinese medicine for treating diabetic feet |
| 09/21/2011 | CN102188650A Traditional Chinese drug for treating diabetic acral necrosis |
| 09/21/2011 | CN102188649A Preparation method of traditional Chinese medicine for treating meat-accumulation type hyperlipidemia |
| 09/21/2011 | CN102188642A Weight-losing and body-building health-care wine and preparation method thereof |
| 09/21/2011 | CN102188626A Traditional Chinese medicine composition capable of treating diabetic peripheral neuropathy |
| 09/21/2011 | CN102188613A Traditional Chinese medicine preparation for treating diabetes |
| 09/21/2011 | CN102188612A Traditional Chinese medicine for treating diabetes mellitus and preparation method thereof |
| 09/21/2011 | CN102188608A Hypoglycemic agent |
| 09/21/2011 | CN102188565A Weight-losing soft capsules and preparation method thereof |
| 09/21/2011 | CN102188560A Traditional Chinese medicine for treating hyperlipidemia |
| 09/21/2011 | CN102188543A Tea polyphenol tablet and preparation method thereof |
| 09/21/2011 | CN102188516A Method for enriching and purifying total flavone in exochorda serratifolia leaves by using macroporous resin |
| 09/21/2011 | CN102188482A Chinese medicine for treating diabetic heart diseases |
| 09/21/2011 | CN102188463A Preparation method of hazel leaf extract |
| 09/21/2011 | CN102188455A Method for extracting totipotent propolis |
| 09/21/2011 | CN102188450A Preparation method of pearl liquid |
| 09/21/2011 | CN102188429A Medicinal composition for treating diabetes |
| 09/21/2011 | CN102188428A Compound preparation of amlodipine and nicotinic acid |
| 09/21/2011 | CN102188427A Double-unit preparation containing simvastatin and niacin |
| 09/21/2011 | CN102188426A Niacin preparation for relieving skin flushing |
| 09/21/2011 | CN102188425A Bilayer tablet containing niacin and simvastatin, and preparation method thereof |
| 09/21/2011 | CN102188421A Fluvastatin preparation without stabilizing agents |
| 09/21/2011 | CN102188419A Single preparations containing fenofibrate and atorvastatin |
| 09/21/2011 | CN102188402A Double-layer tablet containing lovastatin and niacin nicitinic acid |
| 09/21/2011 | CN102188398A Solid preparation containing highly dispersed fenofibrate |
| 09/21/2011 | CN102188374A Medium/long fat emulsion injection and preparation method thereof |
| 09/21/2011 | CN102188370A Resveratrol injection solution and intravenous injection |
| 09/21/2011 | CN102188367A Insulin glargine injecta and preparation method thereof |
| 09/21/2011 | CN101979077B Traditional Chinese medicine for treating heart cerebrovascular diseases |
| 09/21/2011 | CN101890145B Medicament for treating diabetes and preparation thereof |
| 09/21/2011 | CN101791302B Medicinal composition containing sodium ferulate and preparation method thereof |
| 09/21/2011 | CN101773506B Composition of cefpiramide and sodium glycinate or special solvent composition containing sodium glycinate |
| 09/21/2011 | CN101757253B Traditional Chinese medicine and Western medicine composition containing gliquidone |
| 09/21/2011 | CN101716297B Weight-reducing health-care tea |
| 09/21/2011 | CN101690759B Health product for improving nutritional anemia and preparation method thereof |
| 09/21/2011 | CN101623329B Method for extracting paper mulberry alkaloid and application of paper mulberry alkaloid |
| 09/21/2011 | CN101559166B Ophiopogon japonicus extract, preparation method and hypoglycemic application thereof |
| 09/21/2011 | CN101502529B Application of vincetoxicoside B in preparing antidiabetic medicament |
| 09/21/2011 | CN101357181B Medicine containing bupleurum root for treating diabetes and preparation method thereof |
| 09/21/2011 | CN101084009B Gh secretagogues and uses thereof |
| 09/20/2011 | US8022219 2-hydroxymethy1-3,4,5-trihydroxy-1-(4-pentyloxybenzyl) piperidine as glucosylceramide synthase (Gcs) inhibitor |
| 09/20/2011 | US8022079 Methods of modulating PPAR gamma-type receptors |
| 09/20/2011 | US8022065 Purine derivatives as kinase inhibitors |
| 09/20/2011 | US8022062 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists |
| 09/20/2011 | US8022041 Prodrug of an ICE inhibitor |
| 09/20/2011 | US8021853 Inhibition of the β3 subunit of L-type Ca2+ channels |
| 09/20/2011 | US8021838 Transcriptional regulation of target genes |
| 09/20/2011 | US8021693 Methods of organ regeneration using Hox11-expressing pluripotent cells |
| 09/20/2011 | US8021658 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 09/20/2011 | CA2669311C Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof |
| 09/20/2011 | CA2597069C Pyridazine derivatives and their use as therapeutic agents |
| 09/20/2011 | CA2525470C External patch containing estrogen and/or progestogen |
| 09/20/2011 | CA2488723C Use of pullulan as a slowly digested carbohydrate |
| 09/20/2011 | CA2484953C Microbial cellulose wound dressing for treating chronic wounds |
| 09/20/2011 | CA2462903C Beta-lactamyl vasopressin v1a antagonists |
| 09/20/2011 | CA2461812C 3-(arylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 09/20/2011 | CA2458210C Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar-activators |
| 09/20/2011 | CA2455966C Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 09/20/2011 | CA2417904C Compounds acting as melanocortin receptor ligands |
| 09/20/2011 | CA2411726C Use of ingenanes in treating a pkc-related condition or disorder |
| 09/20/2011 | CA2183542C Methods and compositions for stimulating bone cells |
| 09/20/2011 | CA2115828C Calcium receptor active molecules |
| 09/15/2011 | WO2011113065A2 Pegylated polyplexes for polynucleotide delivery |
| 09/15/2011 | WO2011113048A2 Modulation of cytokine signaling |
| 09/15/2011 | WO2011112822A2 Implantable therapeutic device and methods of making |
| 09/15/2011 | WO2011112679A1 Synthesis of alpha-tocopherolquinone derivatives, and methods of using the same |
| 09/15/2011 | WO2011112229A2 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 09/15/2011 | WO2011111817A1 Benzazepine compound |
| 09/15/2011 | WO2011111783A1 Agent for controlling the increase and decrease of lactobacillus bifidus in colon |